After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of MoonLake Immunotherapeutics is $980.67M. A total of 0.91 million shares were traded on the day, compared to an average of 5.22M shares.
In the most recent transaction, Santos da Silva Jorge sold 130,000 shares of MLTX for 15.08 per share on Dec 08 ’25. After the transaction, the Chief Executive Officer now owns 2,948,577 company shares. In a previous transaction on Dec 09 ’25, Santos da Silva Jorge sold 70,000 shares at 14.49 per share. MLTX shares that Chief Executive Officer owns now total 2,878,577.
Among the insiders who sold shares, Reich Kristian disposed of 130,000 shares on Dec 08 ’25 at a per-share price of $15.08. This resulted in the Chief Scientific Officer holding 72,908 shares of MLTX after the transaction. In another insider transaction, Reich Kristian sold 72,908 shares at $14.43 per share on Dec 09 ’25. Company shares held by the Chief Scientific Officer now total 0.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, MLTX has a high of $62.75 and a low of $5.95.
As of this writing, MLTX has an earnings estimate of -$0.99 per share for the current quarter. EPS was calculated based on a consensus of 7.0 estimates, with a high estimate of -$0.88 per share and a lower estimate of -$1.07. The company reported an EPS of -$0.72 in the last quarter
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. MLTX’s latest balance sheet shows that the firm has $8.04M in Cash & Short Term Investments as of fiscal 2021. There were $15.00M in debt and $21.09M in liabilities at the time. Its Book Value Per Share was $4.54, while its Total Shareholder’s Equity was -$11.65M.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for MLTX is Buy with a score of 3.72.
